NEXGEL, Inc. NXGL

Company Overview

NEXGEL, Inc. (NASDAQ: NXGL) is a healthcare and medical products company focused on the development, manufacturing, and commercialization of high-water-content hydrogel products for medical, consumer, and cosmetic applications. The company operates primarily within the advanced wound care, over-the-counter healthcare, beauty, and wellness industries. Its core technology platform is based on proprietary hydrogel formulations designed to provide cooling, hydration, adhesion, and controlled delivery capabilities for topical applications.

The company generates revenue through the sale of branded consumer products, contract manufacturing services, and private-label hydrogel products for commercial partners. Key product categories include wound care dressings, pain management patches, acne and beauty products, and wearable wellness applications. NEXGEL traces its origins to hydrogel manufacturing technologies developed for medical applications and has evolved into a broader consumer health and contract development organization. The company positions itself as a specialized hydrogel manufacturer with vertically integrated production capabilities and regulatory experience in healthcare-related markets.

Business Operations

NEXGEL’s operations are centered around its proprietary hydrogel manufacturing platform and related product commercialization activities. The company manufactures ultra-gentle, high-water-content hydrogels used in products marketed under both owned and partner brands. Its principal operating activities include branded product sales, custom hydrogel manufacturing, and product development partnerships. Revenue is derived from direct-to-consumer sales, retail distribution, e-commerce channels, and manufacturing agreements with third-party healthcare and consumer brands.

The company conducts operations primarily in the United States while also supporting international commercial relationships through distribution and manufacturing partnerships. Key assets include proprietary hydrogel formulations, manufacturing infrastructure, and intellectual property related to topical delivery systems and skin-compatible adhesives. NEXGEL has expanded through acquisitions and partnerships, including ownership interests and operations associated with Silly George, Kenkoderm, and other consumer-focused wellness and beauty brands. The company has also pursued collaborations in wearable technology and therapeutic patch applications tied to sports recovery, pain relief, and skincare markets.

Strategic Position & Investments

NEXGEL’s strategic direction has emphasized expanding its hydrogel technology into higher-growth consumer health and wellness categories while increasing recurring revenue through branded products and manufacturing partnerships. The company has invested in broadening its direct-to-consumer presence, enhancing manufacturing capabilities, and developing new hydrogel-based applications across beauty, medical, and wearable health sectors. Its strategy combines proprietary product commercialization with contract manufacturing services that leverage its production expertise.

Recent strategic initiatives have included acquisitions and investments intended to diversify revenue streams and strengthen consumer brand exposure. The acquisition of Silly George, a beauty-focused brand, expanded the company’s participation in the cosmetics and personal care market. NEXGEL has also pursued growth opportunities tied to wearable health technologies, therapeutic patches, and advanced wound care applications. Public filings and corporate disclosures indicate a focus on scaling commercial distribution, improving operational efficiencies, and increasing penetration across healthcare and consumer wellness channels.

Geographic Footprint

NEXGEL is headquartered in Pennsylvania, United States, and maintains its primary manufacturing and operational activities domestically. The company’s principal commercial market remains the United States, where it distributes products through e-commerce platforms, retail channels, healthcare distributors, and commercial partnerships. Its manufacturing operations are structured to support both internal branded products and third-party customer demand.

In addition to domestic operations, NEXGEL has international commercial exposure through online sales, distribution arrangements, and partner relationships in selected foreign markets. Its hydrogel products and manufacturing capabilities support customers and brands serving markets across North America, parts of Europe, and other international regions through private-label and contract manufacturing arrangements. Public disclosures indicate that international expansion remains opportunistic and tied largely to partnership-driven growth initiatives.

Leadership & Governance

NEXGEL’s leadership team is focused on scaling the company’s hydrogel technology platform through commercialization, operational expansion, and strategic acquisitions. The company emphasizes innovation in healthcare and consumer wellness products while maintaining manufacturing control and regulatory compliance capabilities. Its governance structure includes executives with backgrounds in healthcare, finance, operations, and consumer product commercialization.

Key executives include:

• Adam Levy – Chief Executive Officer
• Andrew J. Eck – Chief Financial Officer
• Jonathan A. Symonds – Chairman of the Board
• Scott Segal – Director
• Matthew J. Harbaugh – Director

Company leadership has consistently communicated a strategy centered on expanding proprietary hydrogel applications, increasing brand ownership, and building long-term growth through both organic product development and acquisition-driven expansion.